1. Home
  2. DLY vs SIBN Comparison

DLY vs SIBN Comparison

Compare DLY & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLY
  • SIBN
  • Stock Information
  • Founded
  • DLY 2019
  • SIBN 2008
  • Country
  • DLY United States
  • SIBN United States
  • Employees
  • DLY N/A
  • SIBN N/A
  • Industry
  • DLY Investment Managers
  • SIBN Medical/Dental Instruments
  • Sector
  • DLY Finance
  • SIBN Health Care
  • Exchange
  • DLY Nasdaq
  • SIBN Nasdaq
  • Market Cap
  • DLY 759.6M
  • SIBN 733.0M
  • IPO Year
  • DLY N/A
  • SIBN 2018
  • Fundamental
  • Price
  • DLY $15.47
  • SIBN $15.68
  • Analyst Decision
  • DLY
  • SIBN Strong Buy
  • Analyst Count
  • DLY 0
  • SIBN 5
  • Target Price
  • DLY N/A
  • SIBN $24.40
  • AVG Volume (30 Days)
  • DLY 215.9K
  • SIBN 444.0K
  • Earning Date
  • DLY 01-01-0001
  • SIBN 08-04-2025
  • Dividend Yield
  • DLY 8.93%
  • SIBN N/A
  • EPS Growth
  • DLY N/A
  • SIBN N/A
  • EPS
  • DLY N/A
  • SIBN N/A
  • Revenue
  • DLY N/A
  • SIBN $185,262,000.00
  • Revenue This Year
  • DLY N/A
  • SIBN $19.48
  • Revenue Next Year
  • DLY N/A
  • SIBN $16.86
  • P/E Ratio
  • DLY N/A
  • SIBN N/A
  • Revenue Growth
  • DLY N/A
  • SIBN 22.93
  • 52 Week Low
  • DLY $13.26
  • SIBN $11.70
  • 52 Week High
  • DLY $15.95
  • SIBN $20.05
  • Technical
  • Relative Strength Index (RSI)
  • DLY 55.26
  • SIBN 37.38
  • Support Level
  • DLY $15.38
  • SIBN $15.11
  • Resistance Level
  • DLY $15.49
  • SIBN $18.34
  • Average True Range (ATR)
  • DLY 0.07
  • SIBN 0.90
  • MACD
  • DLY 0.02
  • SIBN -0.15
  • Stochastic Oscillator
  • DLY 92.31
  • SIBN 17.65

About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest

DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Share on Social Networks: